Nurses Programme

Session 1 Natasha Nunan
10h50 Opening of nurses session – Welcome Natasha Nunan
10h50 to 11h20 Local perspective on apheresis         Dr Yona Skosana (SANBS)
11h20 to 11h50 International perspective on Contamination and Disconnection in Stem Cell Apheresis. Sr Senait Kahsai
DKMS (Germany) 
11h50 to 12h20 Management of patient undergoing apheresis (pbsc collection) – nursing perspective Sr Bridget Mofokeng (SANBS)
12h20 to 12h55 Q & A  
13h00 to 14h00 Lunch
Session 2 Drina Heyns
14h00  to 14h30 Central Line Care and Infection Prevention in HSCT: Small Actions, Big Outcomes Natasha Nunan
14h30 to 15h00 The First 100 Days: Nursing Surveillance After Allogeneic Stem Cell Transplant Shamimah Diedericks
15h00 to 15h20 Oncology Nurse Presentation Tbc (Andrea Brummer)
15h20 to 15h30 Q& A  
15h30 to 16h00 Refreshment break
Session 3 Shamimah Diedericks
16h00 to 16h30 CAR-T, Bispecifics and Blinatumomab: What Transplant Nurses Need to Know (cytokine release syndrome) Drina Heyns
ACT Pretoria
16h30  to 16h45 Onco buddies magazine Karen Joseph
16h45 to 17h20 Oncology presentation 2 TBC
17h20 to 17h30 Q & A  
  Close  

Adcock Ingram is a Proudly South African company. Adcock Ingram manufactures, markets, sells and distributes a wide range of products. The diversified portfolio includes an extensive portfolio of branded and generic prescription medicines.

www.adcock.com

Acino is a Swiss pharmaceutical company headquartered in Zurich with a clear focus on selected markets in the Middle East, Africa, Ukraine and Eurasian countries, and Latin America.

We deliver quality pharmaceuticals to promote affordable healthcare in these emerging markets and leverage our high-quality pharmaceutical manufacturing capabilities and network to supply leading companies through contract manufacturing and out-licensing.

https://acino.swiss/

M-ZA-00002893 Expiration Date 07/03/2027

Roche Pharmaceuticals: Leading the Charge in Oncology

Roche is one of the world’s largest biotechnology company and has spent over 125 years redefining cancer care through a fusion of innovative therapies and precision medicine1.In Africa, Roche is one of the primary drivers of oncology advancements, leveraging a vast clinical trial network to deliver targeted treatments for HER2-positive breast cancer and now incorporating the lung cancer2.


Central to its regional mission is the Africa Breast Cancer Ambition, a bold initiative to rewrite the continent's survival narrative. Currently, only 5 in 10 African women survive breast cancer; Roche aims to increase this to 8 in 103 by 20404. To achieve this, Roche is committed to three critical pillars:

  • Early Detection: Increasing stage I/II diagnoses from 30% to 60%.5
  • Faster Diagnosis: Reducing the journey from symptoms to treatment to just 60 days.6
  • Treatment Access: Ensuring 80% of patients receive the standard of care.7

Through these interventions, Roche is dedicated to doing now what patients need next, pioneering an innovative pipeline to improve clinical outcomes and extend the lives of patients in South Africa.

https://www.roche.co.za/about


Roche Products (Pty) Ltd, P O Box 1469, Halfway House, 1685. Tel. +27-11-504-4746 Registration No. 1947/027044/07 Building E, Hertford Office Park, 90 Bekker Road, Vorna Valley, Midrand, 1686 Directors: R. Ferraro (Chairman) (Swiss) Dr S.D. Diale T.G. (South Africa) Renwick (British)

1 Roche South Africa. About Roche [Internet; updated 2026 Feb; cited 2026 Mar 2]. Available from: About Roche ZA

2 Roche. A new era of healthcare in Africa with AMA [Internet; updated 2026 Feb; cited 2026 Mar 2]. Available from: A new era of healthcare in Africa with AMA

3 Roche. African Breast Cancer Ambition (ABCA) [Internet; cited 2026 Mar 2]. Available from: Africa Breast Cancer Ambition

4 Africa Breast Cancer Council. Our Objectives [Internet; updated 2026; cited 2026 Mar 2]. Available from: Africa Breast Cancer Council Objectives

5 Africa Breast Cancer Council. Our Objectives [Internet; updated 2026; cited 2026 Mar 2]. Available from: Africa Breast Cancer Council Objectives

6 Africa Breast Cancer Council. Our Objectives [Internet; updated 2026; cited 2026 Mar 2]. Available from: Africa Breast Cancer Council Objectives

7 Roche Africa. Working together to help more women in Africa survive breast cancer [Internet; updated 2026 Feb; cited 2026 Mar 2]. Available from: Working together to help more women in Africa survive breast cancer